Abstract

) The Santa Rosa Memorial CCOP is the result of six years of intensive development by a core group of oncologists who serve 90% of the cancer patients in a relatively isolated four county area in Northern California. The 15 physicians who form the Redwood Regional Oncology Group treat 200 new patients per year. The catchment area includes a s i gnificant number of underserved rural, ethnic and socioeconomically disadvantaged individuals for whom the CCOP provides access to state of the art treatment. The program has assembled the necessary resources: an expert data management staff experienced with cooperative group clinical trials, high quality control, hospital resource commitments, involvement of non-oncology specialists. The clinical research team has developed an effective, comprehensive case-finding approach which ensures achievement of CCOP goals. The program's successful track record in cancer control accrual has resulted in 128 persons being registered during the past 22 months as a CCOP.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
2U10CA063850-04
Application #
2008528
Study Section
Special Emphasis Panel (ZCA1-RLB-7 (J2))
Project Start
1994-08-26
Project End
2000-05-31
Budget Start
1997-08-01
Budget End
1998-05-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost

  Institution

Name
Santa Rosa Memorial Hospital
Department
Type
DUNS #
City
Santa Rosa
State
CA
Country
United States
Zip Code
95403

  Publications

Heinrich, Michael C; Rankin, Cathryn; Blanke, Charles D et al. (2017) Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. JAMA Oncol 3:944-952
Wozniak, Antoinette J; Moon, James; Thomas Jr, Charles R et al. (2015) A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer 16:340-7
Erba, Harry P; Othus, Megan; Walter, Roland B et al. (2014) Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432. Leuk Res 38:329-33
Mehta, Rita S; Barlow, William E; Albain, Kathy S et al. (2012) Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med 367:435-44
Tomblyn, Michael B; Goldman, Bryan H; Thomas Jr, Charles R et al. (2012) Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). J Thorac Oncol 7:906-12
Marshall, James R; Tangen, Catherine M; Sakr, Wael A et al. (2011) Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 4:1761-9
Chu, David Z J; Hussey, Michael A; Alberts, David S et al. (2011) Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions. Clin Colorectal Cancer 10:310-6
Herbst, Roy S; Kelly, Karen; Chansky, Kari et al. (2010) Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342. J Clin Oncol 28:4747-54
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010) Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol 28:1247-53
Gitlitz, Barbara J; Moon, James; Glisson, Bonnie S et al. (2010) Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial. J Thorac Oncol 5:1835-40

Showing the most recent 10 out of 63 publications